Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Connecting the dots from Toll-like receptors to innate immune cells and inflammatory bowel disease.

Literature DB >> 12727919

Connecting the dots from Toll-like receptors to innate immune cells and inflammatory bowel disease.

David L Boone¹, Averil Ma.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2003 PMID： 12727919 PMCID： PMC154457 DOI： 10.1172/JCI18545

Source DB: PubMed Journal: J Clin Invest ISSN： 0021-9738 Impact factor: 14.808

× No keyword cloud information.

14 in total

Review 1. Innate immune recognition.

Authors: Charles A Janeway; Ruslan Medzhitov
Journal: Annu Rev Immunol Date: 2001-10-04 Impact factor: 28.527

Review 2. Combining T cells and IL-10: a new therapy for Crohn's disease?

Authors: Karen Madsen
Journal: Gastroenterology Date: 2002-12 Impact factor: 22.682

Review 3. Interleukin-10 and the interleukin-10 receptor.

Authors: K W Moore; R de Waal Malefyt; R L Coffman; A O'Garra
Journal: Annu Rev Immunol Date: 2001 Impact factor: 28.527

Review 4. Lessons from genetically engineered animal models. XII. IL-10-deficient (IL-10(-/-) mice and intestinal inflammation.

Authors: D M Rennick; M M Fort
Journal: Am J Physiol Gastrointest Liver Physiol Date: 2000-06 Impact factor: 4.052

5. Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group.

Authors: S Schreiber; R N Fedorak; O H Nielsen; G Wild; C N Williams; S Nikolaus; M Jacyna; B A Lashner; A Gangl; P Rutgeerts; K Isaacs; S J van Deventer; J C Koningsberger; M Cohard; A LeBeaut; S B Hanauer
Journal: Gastroenterology Date: 2000-12 Impact factor: 22.682

6. Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group.

Authors: R N Fedorak; A Gangl; C O Elson; P Rutgeerts; S Schreiber; G Wild; S B Hanauer; A Kilian; M Cohard; A LeBeaut; B Feagan
Journal: Gastroenterology Date: 2000-12 Impact factor: 22.682

7. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12.

Authors: B Oppmann; R Lesley; B Blom; J C Timans; Y Xu; B Hunte; F Vega; N Yu; J Wang; K Singh; F Zonin; E Vaisberg; T Churakova; M Liu; D Gorman; J Wagner; S Zurawski; Y Liu; J S Abrams; K W Moore; D Rennick; R de Waal-Malefyt; C Hannum; J F Bazan; R A Kastelein
Journal: Immunity Date: 2000-11 Impact factor: 31.745

8. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain.

Authors: Daniel J Cua; Jonathan Sherlock; Yi Chen; Craig A Murphy; Barbara Joyce; Brian Seymour; Linda Lucian; Wayne To; Sylvia Kwan; Tatyana Churakova; Sandra Zurawski; Maria Wiekowski; Sergio A Lira; Daniel Gorman; Robert A Kastelein; Jonathon D Sedgwick
Journal: Nature Date: 2003-02-13 Impact factor: 49.962

9. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils.

Authors: K Takeda; B E Clausen; T Kaisho; T Tsujimura; N Terada; I Förster; S Akira
Journal: Immunity Date: 1999-01 Impact factor: 31.745

10. Toll-like receptor-dependent production of IL-12p40 causes chronic enterocolitis in myeloid cell-specific Stat3-deficient mice.

Authors: Masaya Kobayashi; Mi-Na Kweon; Hirotaka Kuwata; Robert D Schreiber; Hiroshi Kiyono; Kiyoshi Takeda; Shizuo Akira
Journal: J Clin Invest Date: 2003-05 Impact factor: 14.808

7 in total

1. Toll-like receptor 4 and NOD2/CARD15 mutations in Hungarian patients with Crohn's disease: phenotype-genotype correlations.

Authors: Peter Laszlo Lakatos; Laszlo Lakatos; Ferenc Szalay; Claudia Willheim-Polli; Christoph Osterreicher; Zsolt Tulassay; Tamas Molnar; Walter Reinisch; Janos Papp; Gyula Mozsik; Peter Ferenci
Journal: World J Gastroenterol Date: 2005-03-14 Impact factor: 5.742

2. Clostridium butyricum TO-A culture supernatant downregulates TLR4 in human colonic epithelial cells.

Authors: Atsushi Isono; Tatsuro Katsuno; Toru Sato; Tomoo Nakagawa; Yasutaka Kato; Naoki Sato; Gen'ichiro Seo; Yasuo Suzuki; Yasushi Saito
Journal: Dig Dis Sci Date: 2007-04-03 Impact factor: 3.199

Review 3. Current concept on the pathogenesis of inflammatory bowel disease-crosstalk between genetic and microbial factors: pathogenic bacteria and altered bacterial sensing or changes in mucosal integrity take "toll" ?

Authors: Peter Laszlo Lakatos; Simon Fischer; Laszlo Lakatos; Istvan Gal; Janos Papp
Journal: World J Gastroenterol Date: 2006-03-28 Impact factor: 5.742